Literature DB >> 8213085

Neurofibrillary tangles of Guamanian amyotrophic lateral sclerosis, parkinsonism-dementia and neurologically normal Guamanians contain a 4- to 4.5-kilodalton protein which is immunoreactive to anti-amyloid beta/A4-protein antibodies.

D C Guiroy1, M Mellini, M Miyazaki, C Hilbich, J Safar, R M Garruto, R Yanagihara, K Beyreuther, D C Gajdusek.   

Abstract

Neurofibrillary tangles (NFT), one of the neurodegenerative features of Alzheimer's disease, Down's syndrome and normal aging, is a constant, widespread neuropathological finding in Guamanian amyotrophic lateral sclerosis (ALS), parkinsonism-dementia (PD) and in neurologically normal Guamanians, dying of causes other than ALS and PD. NFT in brain tissue sections of patients with Guamanian ALS and PD were immunoreactive to antibodies directed against a 43-amino acid synthetic peptide homologous to amyloid beta/A4-protein (anti-SP43) associated with Alzheimer's disease. NFT extracted from frozen brain tissues of Guamanian patients with ALS and PD and from tissues of neurologically normal Guamanians were congophilic and birefringent. By negative-stain electron microscopy, NFT preparations contained bundles and/or isolated single, straight, unpaired filaments in Guamanian ALS and occasionally pairing of filaments in neurologically normal Guamanians, measuring 5-20 nm in diameter. Formic acid digestion of NFT preparations, followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and size-exclusion high-pressure liquid chromatography, showed a protein with an apparent molecular mass of 4- to 4.5-kDa, which by Western blot analysis was immunoreactive to anti-SP43. Immunoabsorption of purified NFT or SP43 with anti-SP43 abolished immunostaining. Our study corroborate previous data that amyloid beta/A4-protein is present in NFT in Guamanian PD. Furthermore, our data indicate that amyloid beta/A4-protein is present in NFT in brain tissues of patients with Guamanian ALS and in neurologically normal Guamanians, suggesting a common mechanism of amyloidogenesis with NFT formation in Alzheimer's disease and normal brain aging.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213085     DOI: 10.1007/bf00304141

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  49 in total

1.  Straight and paired helical filaments in Alzheimer disease have a common structural unit.

Authors:  R A Crowther
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 2.  Human amyloidosis, Alzheimer disease and related disorders.

Authors:  E M Castaño; B Frangione
Journal:  Lab Invest       Date:  1988-02       Impact factor: 5.662

3.  A low-speed centrifugation technique for the preparation of grids for direct virus examination by electron microscopy.

Authors:  H K Narang; A A Codd
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Neurofilament accumulation induced in synapses by leupeptin.

Authors:  B I Roots
Journal:  Science       Date:  1983-09-02       Impact factor: 47.728

6.  Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants.

Authors:  B H Anderton; D Breinburg; M J Downes; P J Green; B E Tomlinson; J Ulrich; J N Wood; J Kahn
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

7.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

8.  Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies.

Authors:  A Hirano; N Malamud; T S Elizan; L T Kurland
Journal:  Arch Neurol       Date:  1966-07

9.  Cellular and molecular mechanisms of neuronal degeneration: Amyotrophic lateral sclerosis, parkinsonism-demantia, and Alzheimer disease.

Authors:  Ralph M Garruto
Journal:  Am J Hum Biol       Date:  1989       Impact factor: 1.937

10.  Immunoreactive GRP.

Authors:  N Yanaihara; C Yanaihara; T Mochizuki; K Iwahara; T Fujita; T Iwanaga
Journal:  Peptides       Date:  1981       Impact factor: 3.750

View more
  3 in total

1.  Relationship of amyloid beta/A4 protein to the neurofibrillary tangles in Guamanian parkinsonism-dementia.

Authors:  C Schwab; J C Steele; H Akiyama; E G McGeer; P L McGeer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

2.  Intraneuronal Abeta immunoreactivity is not a predictor of brain amyloidosis-beta or neurofibrillary degeneration.

Authors:  Jerzy Wegiel; Izabela Kuchna; Krzysztof Nowicki; Janusz Frackowiak; Bozena Mazur-Kolecka; Humi Imaki; Jarek Wegiel; Pankaj D Mehta; Wayne P Silverman; Barry Reisberg; Mony Deleon; Thomas Wisniewski; Tuula Pirttilla; Harry Frey; Terho Lehtimäki; Tarmo Kivimäki; Frank E Visser; Wouter Kamphorst; Anna Potempska; David Bolton; Julia R Currie; David L Miller
Journal:  Acta Neuropathol       Date:  2007-01-20       Impact factor: 17.088

3.  Dysfunction of Protein Quality Control in Parkinsonism-Dementia Complex of Guam.

Authors:  Bert M Verheijen; Kiyomitsu Oyanagi; Fred W van Leeuwen
Journal:  Front Neurol       Date:  2018-03-20       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.